InvestorsHub Logo
Followers 0
Posts 46
Boards Moderated 0
Alias Born 02/02/2015

Re: None

Wednesday, 08/01/2018 8:37:49 PM

Wednesday, August 01, 2018 8:37:49 PM

Post# of 6316
Finally, a couple items from the 8-K filed today:

"For the purposes of this proposal, AMRI has assumed that the final API material is intended for Phase I Clinical Trials."

Good to see that this is in fact prepared for Phase I Clinical Trials. Anyone else think it's strange that NMUS didn't specify that this was for Phase I and AMRI had to assume it was? Weird...


"Process Development Including Analytical Support
Description [****]
Estimated Labor Fee [****]
Reimbursable Expenses [****]
Anticipated Timeframe [****]"

I get the confidentiality, but typical NMUS to be as least descriptive as possible.

What if NMUS cancels this agreement? Will we be informed?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SKYE News